Clinical and patient reported treatment outcomes of livedoid vasculopathy: a systematic review.

COI Statement

Conflicts of interest: A.G.O.-L is President of the Pacific Dermatologic Association, a member of the Honorary Editorial Board of the American Journal of Clinical Dermatology and Associate Editor of Dermatology (Karger). He has served as a consultant for Genentech, Guidepoint, Corvus Pharmaceuticals, Castle Biosciences, Clarivate, InflaRx GmbH, TFS HealthScience and Otsuka. He is on the advisory board for Bristol Meyer Squibb, Boehringer Ingelheim, Janssen, Sanofi and Biotech, and has received research grants from AbbVie, Lilly, Janssen, Pfizer, Incyte, Boehringer Ingelheim and InflaRx GmbH. He is also supported by NIH NIAMS R01 AR083110. The other authors declare no conflicts of interest.